Chronic heart failure: we are fighting the battle, but are we winning the war?

John J Atherton1

  • 1Cardiology Department, Royal Brisbane and Women's Hospital, Butterfield Street, Herston, QLD 4006, Australia ; School of Medicine, University of Queensland, Brisbane, QLD 4006, Australia.

Scientifica
|November 27, 2013
PubMed

Insights

Heart failure management has advanced, but prevalence is rising. Future strategies must combine improved treatments with proactive public health measures and early screening for high-risk individuals.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Heart failure is a serious condition with poor prognosis, despite advances in neurohormonal blockade and device therapies like implantable cardioverter defibrillators and cardiac resynchronization therapy.
  • Prevalence of heart failure is increasing due to an aging population and improved survival rates for cardiovascular disease patients.

Purpose of the Study:

  • To highlight treatment gaps and variations in evidence-based practice for heart failure.
  • To emphasize the need for a comprehensive strategy addressing both treatment and prevention to combat the rising prevalence of heart failure.

Main Methods:

  • Analysis of registry data to identify treatment gaps and variations in evidence-based practice.
  • Review of quality improvement initiatives and multidisciplinary heart failure disease management programs.
  • Discussion of the necessity for public health measures and screening strategies for future prevention.

Main Results:

  • Registries reveal significant gaps in the application of evidence-based heart failure treatments, including echocardiography and disease-modifying drugs.
  • Quality initiatives and multidisciplinary management improve self-care and reduce practice variation, leading to better outcomes.
  • Current approaches are insufficient to curb the rising prevalence of heart failure.

Conclusions:

  • While advanced treatments have improved survival, they have not halted the increasing incidence of heart failure.
  • Effective control of heart failure requires a dual approach: optimizing current evidence-based treatments and implementing robust disease prevention strategies.
  • Future efforts must integrate population-level public health interventions and targeted screening to identify and manage individuals at high risk of developing heart failure.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2.0K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
807
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
5.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.2K